A fascinating discussion on the following topics: Probabilistic thinking The art and science of investing Scaling a company vs Person Decision making process ESG and implications in biotech
Avoiding stupidity is easier than seeking Brilliance – thats the essence of Subtractive knowledge. We always tend to consider positive points to create value, but many times we cannot be confident if those positive points will work. Hence, eliminating the…
In this video we talk about the book by David Foster Wallace. The book provides the essence of how we view our life and how we make certain decisions.
In this video we discuss several things : Current biotech market crash Assessing the risk of the assets Evaluating deals
In this video we discuss with the Managing Partner of Umbrex and Ex CEO of Atenua Mr. Jing Liang, how he decided to liquidate his company once his lead product failed. Also we discuss other strategies and opportunities this market…
In this video we discuss the concepts of Power law which is widely knows as 80/20 rule. When a Biotech CEO has to make a presentation on the deals done in the therapeutic area, most of the time, they present…
In this video we discuss with Tomas Eriksson, distractions, meetings and how it affects the productivity of the team.
In this video we discuss several fundamental points about risks. One of them is that Risk is always in the future and many things that happened in the past may not happen tomorrow.
In this video, we discuss with Guillem, Partner at Ysios Capital about : Tacit knowledge, Scale and how Investors select a biotech/medtech company.
In this video we talk about Rene Girard’s mimetic desire and how having awareness of this can allow to navigate our desires better. Most importantly, we use these concepts to understand how a Biotech/Medtech CEO can make better decisions.